2008 Woodie Awards
Flu study could mean cash for students
By: Laura Brian
Issue date: 10/15/07 Section: News
- Page 1 of 1
For most people, getting the flu is a bad thing.
But for researchers at Central Michigan University and their research partners, light infection rates hamper their study sample.
CMU is working with University of Michigan's School of Public Health Department to compare influenza vaccinations methods, said Sarah Campbell, director of University Health Services.
The first study was in 2004 to 2005 had more than 1,200 Michiganders aged 18 to 46 participating.
"The reason we were able to write a major paper in (2004-2005) was that there was a typical amount of influenza in that year," said Arnold Monto, University of Michigan epidemiology professor and study researcher. "The next two years (2005 and 2006) were light flu years, making it hard to draw conclusions."
The flu shot (inactivated vaccine) proved more efficient than nasal spray (live attenuated vaccine) in preventing influenza ,according to the study.
Participants were randomly given the inactivated vaccine, live attenuated vaccine or a placebo.
Students can get $100 by taking the flu vaccine for this year's survey.
Monto said previous participants and newcomers are welcome.
"They come to be seen three times - around now, three weeks later and in April," he said. "Participants are paid for their time and reporting illnesses."
Participants will give a sample of their blood during each visit and be paid $60 on their second visit. They will receive an additional $40 on their third visit, Monto said.
Participants who get sick will get $25 added to their last paycheck if they come in for an illness sample visit, which is a throat swab, he said.
Sign-up will take place from 8 a.m. to 5 p.m. Monday to Friday in Foust 104. Participants will be accepted until Thanksgiving.
Campbell said the most recent study consisted of more than 600 participants at CMU Health Services. Five of every six participants received the actual vaccine, while the sixth received a placebo. Neither the participant nor the vaccinator knew who received what, she said.
The one-year study comparing flu vaccinations began Oct. 1 and is funded by the pharmaceutical company, Sanofi Pasteur, which produces the influenza vaccine, Campbell said.
"We also plan to submit a new proposal to the NIH (National Institutes of Health) for another multi-year study beginning in the 2008-2009 academic school year," she said.
news@cm-life.com
But for researchers at Central Michigan University and their research partners, light infection rates hamper their study sample.
CMU is working with University of Michigan's School of Public Health Department to compare influenza vaccinations methods, said Sarah Campbell, director of University Health Services.
The first study was in 2004 to 2005 had more than 1,200 Michiganders aged 18 to 46 participating.
"The reason we were able to write a major paper in (2004-2005) was that there was a typical amount of influenza in that year," said Arnold Monto, University of Michigan epidemiology professor and study researcher. "The next two years (2005 and 2006) were light flu years, making it hard to draw conclusions."
The flu shot (inactivated vaccine) proved more efficient than nasal spray (live attenuated vaccine) in preventing influenza ,according to the study.
Participants were randomly given the inactivated vaccine, live attenuated vaccine or a placebo.
Students can get $100 by taking the flu vaccine for this year's survey.
Monto said previous participants and newcomers are welcome.
"They come to be seen three times - around now, three weeks later and in April," he said. "Participants are paid for their time and reporting illnesses."
Participants will give a sample of their blood during each visit and be paid $60 on their second visit. They will receive an additional $40 on their third visit, Monto said.
Participants who get sick will get $25 added to their last paycheck if they come in for an illness sample visit, which is a throat swab, he said.
Sign-up will take place from 8 a.m. to 5 p.m. Monday to Friday in Foust 104. Participants will be accepted until Thanksgiving.
Campbell said the most recent study consisted of more than 600 participants at CMU Health Services. Five of every six participants received the actual vaccine, while the sixth received a placebo. Neither the participant nor the vaccinator knew who received what, she said.
The one-year study comparing flu vaccinations began Oct. 1 and is funded by the pharmaceutical company, Sanofi Pasteur, which produces the influenza vaccine, Campbell said.
"We also plan to submit a new proposal to the NIH (National Institutes of Health) for another multi-year study beginning in the 2008-2009 academic school year," she said.
news@cm-life.com
Be the first to comment on this story